ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is KYORIN Pharmaceutical Co., Ltd. ?
1
Company's ability to service its debt is strong with a healthy EBIT to Interest (avg) ratio of 80.38
2
Poor long term growth as Net Sales has grown by an annual rate of 3.41% and Operating profit at 10.88% over the last 5 years
3
The company declared positive results in Mar'25 after very negative results in Dec'24
- NET PROFIT(HY) Higher at JPY 8,817.39 MM
- ROCE(HY) Highest at 7.74%
- RAW MATERIAL COST(Y) Fallen by -0.99% (YoY)
4
With ROE of 6.67%, it has a very attractive valuation with a 0.71 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 1.22%, its profits have risen by 53.3% ; the PEG ratio of the company is 0.2
5
Underperformed the market in the last 1 year
- The stock has generated a return of 1.22% in the last 1 year, much lower than market (Japan Nikkei 225) returns of 28.54%
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to KYORIN Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is KYORIN Pharmaceutical Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
KYORIN Pharmaceutical Co., Ltd.
1.22%
-0.39
28.85%
Japan Nikkei 225
28.54%
1.11
25.75%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
3.41%
EBIT Growth (5y)
10.88%
EBIT to Interest (avg)
80.02
Debt to EBITDA (avg)
0.31
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.79
Tax Ratio
28.85%
Dividend Payout Ratio
32.88%
Pledged Shares
0
Institutional Holding
0.11%
ROCE (avg)
5.21%
ROE (avg)
4.44%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.71
EV to EBIT
8.59
EV to EBITDA
6.28
EV to Capital Employed
0.73
EV to Sales
0.83
PEG Ratio
0.20
Dividend Yield
NA
ROCE (Latest)
8.50%
ROE (Latest)
6.67%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
NET PROFIT(HY)
Higher at JPY 8,817.39 MM
ROCE(HY)
Highest at 7.74%
RAW MATERIAL COST(Y)
Fallen by -0.99% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 3.11%
-11What is not working for the Company
INTEREST(HY)
At JPY 134 MM has Grown at 282.86%
INVENTORY TURNOVER RATIO(HY)
Lowest at 1.14%
NET SALES(Q)
At JPY 30,229 MM has Fallen at -7.05%
Here's what is working for KYORIN Pharmaceutical Co., Ltd.
Net Profit
At JPY 8,817.39 MM has Grown at 303.44%
Year on Year (YoY)MOJO Watch
Net Profit trend is very positive
Net Profit (JPY MM)
Net Profit
Higher at JPY 8,817.39 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (JPY MM)
Debtors Turnover Ratio
Highest at 3.11%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -0.99% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for KYORIN Pharmaceutical Co., Ltd.
Interest
At JPY 134 MM has Grown at 282.86%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Inventory Turnover Ratio
Lowest at 1.14% and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Net Sales
At JPY 30,229 MM has Fallen at -7.05%
over average net sales of the previous four periods of JPY 32,521.75 MMMOJO Watch
Near term sales trend is negative
Net Sales (JPY MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
